Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Related Articles by Review for PubMed (Select 20406807)

1.

Structural properties of HIV integrase. Lens epithelium-derived growth factor oligomers.

Gupta K, Diamond T, Hwang Y, Bushman F, Van Duyne GD.

J Biol Chem. 2010 Jun 25;285(26):20303-15. doi: 10.1074/jbc.M110.114413. Epub 2010 Apr 20.

2.

The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.

Christ F, Debyser Z.

Virology. 2013 Jan 5;435(1):102-9. doi: 10.1016/j.virol.2012.09.033. Review. Erratum in: Virology. 2013 Mar 30;438(1):50.

3.

Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75.

De Luca L, Ferro S, Morreale F, De Grazia S, Chimirri A.

ChemMedChem. 2011 Jul 4;6(7):1184-91. doi: 10.1002/cmdc.201100071. Epub 2011 Apr 19. Review.

PMID:
21506277
4.

Inhibition of the interaction between HIV-1 integrase and its cofactor LEDGF/p75: a promising approach in anti-retroviral therapy.

De Luca L, Ferro S, Morreale F, Chimirri A.

Mini Rev Med Chem. 2011 Jul;11(8):714-27. Review.

PMID:
21651465
5.

Integrase, LEDGF/p75 and HIV replication.

Poeschla EM.

Cell Mol Life Sci. 2008 May;65(9):1403-24. doi: 10.1007/s00018-008-7540-5. Review.

6.

[LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].

Chen WM, Liu XY.

Yao Xue Xue Bao. 2009 Sep;44(9):953-60. Review. Chinese.

PMID:
20055168
7.

The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication.

Engelman A, Cherepanov P.

PLoS Pathog. 2008 Mar 28;4(3):e1000046. doi: 10.1371/journal.ppat.1000046. Review.

8.

Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors.

Jurado KA, Engelman A.

Expert Rev Mol Med. 2013 Nov 26;15:e14. doi: 10.1017/erm.2013.15. Review.

9.

Characterization and structural analysis of HIV-1 integrase conservation.

Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, Perno CF.

AIDS Rev. 2009 Jan-Mar;11(1):17-29. Review.

PMID:
19290031
10.

Retroviral integrase proteins and HIV-1 DNA integration.

Krishnan L, Engelman A.

J Biol Chem. 2012 Nov 30;287(49):40858-66. doi: 10.1074/jbc.R112.397760. Epub 2012 Oct 5. Review.

11.

Cellular co-factors of HIV-1 integration.

Van Maele B, Busschots K, Vandekerckhove L, Christ F, Debyser Z.

Trends Biochem Sci. 2006 Feb;31(2):98-105. Epub 2006 Jan 5. Review.

PMID:
16403635
12.

New approaches for inhibiting HIV integrase: a journey beyond the active site.

Walker MA.

Curr Opin Investig Drugs. 2009 Feb;10(2):129-36. Review.

PMID:
19197790
13.

HIV DNA integration.

Craigie R, Bushman FD.

Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006890. doi: 10.1101/cshperspect.a006890. Review.

14.

HIV-1 integrase multimerization as a therapeutic target.

Feng L, Larue RC, Slaughter A, Kessl JJ, Kvaratskhelia M.

Curr Top Microbiol Immunol. 2015;389:93-119. doi: 10.1007/82_2015_439. Review.

PMID:
25778682
15.

Posttranslational modifications of HIV-1 integrase by various cellular proteins during viral replication.

Zheng Y, Yao X.

Viruses. 2013 Jul 16;5(7):1787-801. doi: 10.3390/v5071787. Review.

16.

Sending signals dynamically.

Smock RG, Gierasch LM.

Science. 2009 Apr 10;324(5924):198-203. doi: 10.1126/science.1169377. Review.

17.

Leonidas Zervas award lecture: abiotic ligands for new quaternary architectures of peptides and proteins.

Jensen KJ.

J Pept Sci. 2013 Sep;19(9):537-44. doi: 10.1002/psc.2545. Epub 2013 Aug 11. Review.

PMID:
23934734
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk